| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
|
Ginzac, Angeline
|
|
|
93 |
3 |
p. 225-236
|
article
|
| 2 |
Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects
|
Nirogi, Ramakrishna
|
|
|
93 |
3 |
p. 253-264
|
article
|
| 3 |
Effect of vitamin E on doxorubicin and paclitaxel-induced memory impairments in male rats
|
Altarifi, Ahmad A.
|
|
|
93 |
3 |
p. 215-224
|
article
|
| 4 |
Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer
|
Xu, Shengxi
|
|
|
93 |
3 |
p. 191-202
|
article
|
| 5 |
Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway
|
Huang, Liru
|
|
|
93 |
3 |
p. 203-213
|
article
|
| 6 |
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
|
Mittra, Arjun
|
|
|
93 |
3 |
p. 177-189
|
article
|
| 7 |
Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma
|
Yasuda, Hajime
|
|
|
93 |
3 |
p. 265-268
|
article
|
| 8 |
Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer
|
Lin, Xingyi
|
|
|
93 |
3 |
p. 237-251
|
article
|
| 9 |
Retraction Note: Atrial natriuretic peptide protects against cisplatin‑induced granulocytopenia
|
Nojiri, Takashi
|
|
|
93 |
3 |
p. 271
|
article
|
| 10 |
Retraction Note: Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis
|
Nigam, Nidhi
|
|
|
93 |
3 |
p. 269
|
article
|
Journal description